Dare Bioscience DARE
NASDAQ DARE
$0.68 -0.01 (-1.26%)
As of: Oct 21, 2026 · 3:49 PM EDT

Dare Bioscience (DARE) Receivables (2013 - 2022)

Updated

Dare Bioscience (DARE) recorded Receivables of $12.14 million in Q2 2022.

Analysis

Dare Bioscience (DARE) Receivables (2013 - 2022) Analysis & Trends

At the end of FY2021, Dare Bioscience reported Receivables of $1.15 million.

  • Annual Receivables has a five-year compound annual growth rate of -9.0% (FY2016 to FY2021).
  • The Q2 2022 figure is the highest quarterly Receivables in data going back to Q4 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 19.05 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 13.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 5.06 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 12.49 Bn
10 Dare Bioscience 10.13 Mn -55.33 Mn -132,343.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 12.14 Mn
Dec 31, 2021 1.15 Mn
Jun 30, 2017 890,000.00
Mar 31, 2017 1.14 Mn
Dec 31, 2016 1.84 Mn
Sep 30, 2016 1.15 Mn
Jun 30, 2016 1.73 Mn
Mar 31, 2016 1.59 Mn
Dec 31, 2015 1.39 Mn
Sep 30, 2015 1.52 Mn
Jun 30, 2015 1.61 Mn
Mar 31, 2015 2.27 Mn
Dec 31, 2014 1.66 Mn
Sep 30, 2014 1.91 Mn
Jun 30, 2014 1.12 Mn
Mar 31, 2014 3.03 Mn
Dec 31, 2013 959,000.00
API Access

Dare Bioscience Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=DARE&period=max&api_key=YOUR_API_KEY